↓ Skip to main content

Treatment options for diabetes: Potential role of stem cells

Overview of attention for article published in Diabetes Research & Clinical Practice, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment options for diabetes: Potential role of stem cells
Published in
Diabetes Research & Clinical Practice, September 2012
DOI 10.1016/j.diabres.2012.09.010
Pubmed ID
Authors

Jamil Stanekzai, Esma R. Isenovic, Shaker A. Mousa

Abstract

There are diseases and injuries in which a patient's cells or tissues are destroyed that can only be adequately corrected by tissue or organ transplants. Stem cells may be able to generate new tissue and even cure diseases for which there is no adequate therapy. Type 1 diabetes (T1DM), an insulin-dependent diabetes, is a chronic disease affecting genetically predisposed individuals, in which insulin-secreting beta (β)-cells within pancreatic islets of Langerhans are selectively and irreversibly destroyed by autoimmune assault. Type 2 diabetes (T2DM) is characterized by a gradual decrease in insulin sensitivity in peripheral tissues and the liver (insulin resistance), followed by a gradual decline in β-cell function and insulin secretion. Successful replacing of damaged β-cells has shown considerable potential in treating T1DM, but lack of adequate donors is a barrier. The literature suggests that embryonic and adult stem cells are promising alternatives in long-term treatment of diabetes. However, any successful strategy should address both the need for β-cell replacement and controlling the autoimmune response to cells that express insulin. This review summarizes the current knowledge of options and the potential of stem cell transplantation in diabetes treatment.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 85 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 24%
Student > Master 14 16%
Student > Ph. D. Student 13 15%
Student > Doctoral Student 8 9%
Researcher 8 9%
Other 15 18%
Unknown 7 8%
Readers by discipline Count As %
Agricultural and Biological Sciences 24 28%
Medicine and Dentistry 16 19%
Biochemistry, Genetics and Molecular Biology 10 12%
Engineering 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 13 15%
Unknown 12 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2012.
All research outputs
#15,168,167
of 25,371,288 outputs
Outputs from Diabetes Research & Clinical Practice
#1,895
of 3,191 outputs
Outputs of similar age
#110,717
of 190,785 outputs
Outputs of similar age from Diabetes Research & Clinical Practice
#16
of 35 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,191 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,785 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.